Venous angioplasty for "CCSVI" in multiple sclerosis: ending a therapeutic misadventure

Affiliations

¹ From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. bourdett@ohsu.edu.
² From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH.

Editorial

Dennis N Bourdette et al. Neurology. 2014.

. 2014 Jul 29;83(5):388-9.

doi: 10.1212/WNL.0000000000000651. Epub 2014 Jun 27.

¹ From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. bourdett@ohsu.edu.
² From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH.

No abstract available

Comment on

Prospective randomized trial of venous angioplasty in MS (PREMiSe).
Siddiqui AH, Zivadinov R, Benedict RH, Karmon Y, Yu J, Hartney ML, Marr KL, Valnarov V, Kennedy CL, Ramanathan M, Ramasamy DP, Dolic K, Hojnacki DW, Carl E, Levy EI, Hopkins LN, Weinstock-Guttman B. Siddiqui AH, et al. Neurology. 2014 Jul 29;83(5):441-9. doi: 10.1212/WNL.0000000000000638. Epub 2014 Jun 27. Neurology. 2014. PMID: 24975855 Free PMC article. Clinical Trial.